Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Hims & Hers Health Q2 2024 GAAP EPS $0.06 Beats $0.03 Estimate, Sales $315.648M Beat $299.942M Estimate

Author: Benzinga Newsdesk | August 05, 2024 04:07pm
Hims & Hers Health (NYSE:HIMS) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.03 by 100 percent. This is a 300 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $315.648 million which beat the analyst consensus estimate of $299.942 million by 5.24 percent. This is a 51.82 percent increase over sales of $207.912 million the same period last year.

Posted In: HIMS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist